Best Urologists and Urinary Tract Doctors in Cortlandt Manor, NY

Dr. Gregory Joice, MD is an Urology Specialist who practices in Cortlandt Manor, NY. He has been practicing for 11 years. Dr. Gregory Joice, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University. Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer. Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

Dr. Izak Faiena MD, MSCR is a urologic oncologist with a specialized focus on prostate cancer. His expertise spans advanced diagnostic techniques, such as MRI fusion and transperineal biopsy, as well as cutting-edge treatments including focal therapy and robotic surgery. With a solid foundation from the Albert Einstein College of Medicine, where he graduated with Alpha Omega Alpha honors, Dr. Faiena went on to complete his urology residency at Rutgers Robert Wood Johnson Medical School. During this time, he earned multiple research awards for his contributions to prostate and bladder cancer studies. Following his residency, Dr. Faiena pursued a fellowship in urologic oncology and earned a Master's in Clinical Research from the esteemed UCLA Institute of Urologic Oncology and the Clinical and Translational Science Institute. His work here garnered significant research funding and resulted in impactful publications on clinical trials in urologic cancers. Currently, Dr. Faiena is dedicated to advancing the field of prostate cancer through innovative clinical trials, targeting both localized and advanced stages of the disease. His groundbreaking research has been featured in top national and international medical journals, reflecting his commitment to improving patient outcomes and advancing cancer care.

Dr. Gregory Joice, MD is an Urology Specialist who practices in Cortlandt Manor, NY. He has been practicing for 11 years. Dr. Gregory Joice, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University. Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer. Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Dr. Izak Faiena MD, MSCR is a urologic oncologist with a specialized focus on prostate cancer. His expertise spans advanced diagnostic techniques, such as MRI fusion and transperineal biopsy, as well as cutting-edge treatments including focal therapy and robotic surgery. With a solid foundation from the Albert Einstein College of Medicine, where he graduated with Alpha Omega Alpha honors, Dr. Faiena went on to complete his urology residency at Rutgers Robert Wood Johnson Medical School. During this time, he earned multiple research awards for his contributions to prostate and bladder cancer studies. Following his residency, Dr. Faiena pursued a fellowship in urologic oncology and earned a Master's in Clinical Research from the esteemed UCLA Institute of Urologic Oncology and the Clinical and Translational Science Institute. His work here garnered significant research funding and resulted in impactful publications on clinical trials in urologic cancers. Currently, Dr. Faiena is dedicated to advancing the field of prostate cancer through innovative clinical trials, targeting both localized and advanced stages of the disease. His groundbreaking research has been featured in top national and international medical journals, reflecting his commitment to improving patient outcomes and advancing cancer care.